Lantheus Holdings Explained

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.[1] [2]

Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc.[3] (formerly BMS Medical Imaging), Progenics Pharmaceuticals (acquired 2020),[4] [5] Inc. and EXINI Diagnostics AB (est. 1999, acquired 2020).[6] Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.[7] [8] [9]

Notes and References

  1. Web site: Lantheus Holdings Inc Company Profile . GlobalData . 2024-05-06.
  2. Web site: SEC Filing . Lantheus Holdings, Inc. . 2016-06-30 . 2024-05-06.
  3. Web site: Lantheus Medical Imaging Inc . Bloomberg.com . 2024-05-06. develops, manufactures, and distributes diagnostic imaging products. The Company offers imaging agents that assist in the diagnosis of heart, vascular, and other diseases using nuclear imaging, echocardiography, and magnetic resonance imaging (MRI) technologies. Lantheus Medical Imaging markets its products worldwide..
  4. Web site: Progenics Pharmaceuticals, Inc. . LinkedIn . 2018-09-01 . 2024-05-06.
  5. Web site: Name . Drug . Technetium Tc 99m trofolastat . AdisInsight . 2022-04-13 . 2024-05-06.
  6. Web site: We empower patients for better healthcare with Artificial Intelligence . Exini Diagnostics AB . 2024-02-06 . 2024-05-06. ...established in 1999 to commercialize AI methods for automated analysis of diagnostic images developed by a research group at Lund University. As a certified medical device manufacturer, EXINI has developed automated analysis platforms for cardiac, brain and bone scans. The company has always been innovative, developing web-based systems in the early 2000s. EXINIs most widely distributed platform is used to calculate the automated Bone Scan Index, which quantifies the bone tumor burden in patients with metastatic prostate cancer..
  7. Web site: Legal Notice . Lantheus . 2023-03-01 . 2024-05-06.
  8. Lantheus Medical Imaging . Journal of Nuclear Medicine Technology . Society of Nuclear Medicine . 48 . Supplement 1 . 2020-06-01 . 0091-4916 . 32605966 . 87S–87S . 2024-05-06.
  9. Web site: SEC.gov . XML 32 R8.htm IDEA: XBRL DOCUMENT . 2020-03-31 . 2024-05-06.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Lantheus Holdings".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.